pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
Stem Cell Therapy for Coronavirus Disease 2019 (COVID-19)
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Cyclooxygenase
Stemedica Cell Technologies Inc
0 catalysts
Preclinical
Stem Cell Therapy for Ophthalmology
University of California Los Angeles
0 catalysts
Phase 2
Stemchymal
Spinocerebellar Ataxia (SCA)
Steminent Biotherapeutics Inc
0 catalysts
← prev
page 162 of 271
next →
131
Pain89
Neurology1
Phase 2
Stenoparib
Epithelial Ovarian Cancer
Tankyrase 1/2Poly [ADP-ribose] polymerase 2
$ALLRAllarity Therapeutics, Inc.
0 catalysts
Phase 2
Streptococcus vaccine
Streptococcal Infections
Minervax ApS
0 catalysts
Preclinical
StroMel
Osteoarthritis
Akan Biosciences LLC
0 catalysts
Marketed
Strontium chloride Sr 89
Strontium Chloride SR-89 (strontium chloride)
Ostealgia (Bone Pain)
Q BioMed Inc
0 catalysts
Marketed
Subvenite
Subvenite (lamotrigine)
Bipolar Disorder (Manic Depression)
OWP Pharmaceuticals Inc
0 catalysts
Marketed
Succinylcholine Chloride Hikma
Succinylcholine Chloride (succinylcholine chloride)
Muscle Relaxation
Hikma Pharmaceuticals USA Inc
0 catalysts
Marketed
Sular
Nisoldipine Prasco (nisoldipine)
Angina (Angina Pectoris)
Prasco LLC
0 catalysts
Marketed
Sulindac Teva
Sulindac (sulindac)
Osteoarthritis Pain
Teva Pharmaceuticals USA Inc
0 catalysts
Preclinical
SuppoCan
Inflammatory Bowel Disease
$IXHLIncannex Healthcare Inc.
0 catalysts
Marketed
Suprax
Suprax (cefixime)
Urinary Tract Infections
Lupin Ltd
0 catalysts
Phase 2
SurVaxM
Glioblastoma Multiforme (GBM)
Baculoviral IAP repeat-containing protein 5Hemocyanin 1
MimiVax LLC
0 catalysts
Marketed
Syfovre
Syfovre (pegcetacoplan)
Geographic Atrophy
$APLSApellis Pharmaceuticals, Inc.
0 catalysts
Marketed
Sylatron
Sylatron (peginterferon alfa-2b)
Melanoma
$MRKMerck & Co., Inc.
0 catalysts
Phase 1
SynKIR-110
Bile Duct Cancer (Cholangiocarcinoma)
Verismo Therapeutics Inc
0 catalysts
Phase 1
SynKIR-310
Diffuse Large B-Cell Lymphoma
Verismo Therapeutics Inc
0 catalysts
Preclinical
Synthetic Transporter
Menkes Disease (Kinky Hair Disease)
University of Lorraine
0 catalysts
Phase 1
T-1101
Neuroendocrine Tumors
Taivex Therapeutics Inc
0 catalysts
Phase 2
T-3D959
Alzheimer's Disease
T3D Therapeutics Inc
0 catalysts
Preclinical
T-Cell Therapy
Solid Tumor
Eureka Therapeutics Inc
0 catalysts
Phase 2
TACROLIMUS
TACROLIMUS (TACROLIMUS)
Hemorrhagic Cystitis (Haemorrhagic Cystitis)
Peptidyl-prolyl cis-trans isomerase FKBP1A
$LIPOLIPELLA PHARMACEUTICALS INC.
0 catalysts
TAFINLAR
TAFINLAR (DABRAFENIB MESYLATE)
1 INDICATIONS AND USAGE TAFINLAR is a kinase inhibitor indicated as a single…
Serine/threonine-protein kinase B-raf
$NVSNOVARTIS AG
0 catalysts
Preclinical
TAGX-0004
Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease)
TagCyx Biotechnologies
0 catalysts
Phase 2
TAK-101
Celiac Disease
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Phase 2
TAK-360
Type 2 Narcolepsy (Narcolepsy without Cataplexy)
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Phase 3
TAK-881
Primary Immune Deficiency (PID)
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
TALVEY
TALVEY (TALQUETAMAB-TGVS)
Janssen Biotech Inc
0 catalysts
Marketed
TAPENTADOL HYDROCHLORIDE
TAPENTADOL HYDROCHLORIDE (TAPENTADOL HYDROCHLORIDE)
Pain
Hikma Pharmaceuticals Plc
0 catalysts